Mon. 3 Jun 2024, 7:11am ET
Benzinga
Biotech, News, Health Care, General
- Significant Reduction in Dehydroepiandrosterone Sulfate (DHEAS) Versus Placebo Observed in Women with Elevated DHEAS Levels at Baseline
- Increase in Serum Sex Hormone Binding Globulin (SHBG) Versus Placebo Observed
- Tildacerfont was Well-Tolerated with No Safety Signals